SMTL ID : 2gqg.1 (1 other biounit)

X-ray Crystal Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x 1N1: N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE(Non-covalent)

1N1.1: 18 residues within 4Å: Chain A: L.26, Y.31, A.47, V.48, K.49, E.64, M.68, V.77, I.91, T.93, E.94, F.95, M.96, T.97, Y.98, G.99, L.148, A.158 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.26, A:L.26, A:K.49, A:V.77, A:I.91, A:T.93, A:F.95, A:A.158 Hydrogen bonds: A:T.93, A:M.96, A:M.96

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tokarski, J.S. et al., The Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain Elucidates Its Inhibitory Activity against Imatinib-Resistant ABL Mutants. CANCER RES. (2006)

Release Date

2006-11-21

Peptides

Proto-oncogene tyrosine-protein kinase ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase ABL1

Related Entries With Identical Sequence